Hassan Ashktorab
Overview
Explore the profile of Hassan Ashktorab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
211
Citations
4002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah D, Thaweethai T, Karlson E, Bonilla H, Horne B, Mullington J, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2455430.
PMID: 39841477
Importance: A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long...
2.
Yoon J, Kim J, Eun J, Ashktorab H, Smoot D, Nam S, et al.
Cell Commun Signal
. 2025 Jan;
23(1):35.
PMID: 39833908
Background: Gastric cancer remains a significant global health challenge, characterized by poor prognosis and high mortality rates. Mitotic integrity and genomic stability are crucial in maintaining cellular homeostasis and preventing...
3.
Vernon S, Zheng T, Do H, Marconi V, Jason L, Singer N, et al.
J Gen Intern Med
. 2025 Jan;
PMID: 39804551
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may occur after infection. How often people develop ME/CFS after SARS-CoV-2 infection is unknown. Objective: To determine the incidence and prevalence of post-COVID-19 ME/CFS...
4.
Geng L, Erlandson K, Hornig M, Letts R, Selvaggi C, Ashktorab H, et al.
JAMA
. 2024 Dec;
333(8):694-700.
PMID: 39693079
Importance: Classification of persons with long COVID (LC) or post-COVID-19 condition must encompass the complexity and heterogeneity of the condition. Iterative refinement of the classification index for research is needed...
5.
Brim H, Reddy C, Chirumamilla L, Oskrochi G, Deverapalli M, Rashid R, et al.
Dig Dis Sci
. 2024 Nov;
70(1):168-176.
PMID: 39586927
Background: The proportion of early onset colorectal cancer (EOCRC) is alarming in adults, including in African Americans (AA). Aim: To investigate differences between EOCRC compared to late-onset colorectal cancer (LOCRC)...
6.
Choi S, Yoon C, Park M, Lee D, Kook M, Lin J, et al.
Mol Cancer Res
. 2024 Nov;
22(11):1065.
PMID: 39482974
No abstract available.
7.
Cho S, Yoon C, Lee J, Chang K, Lin J, Kim Y, et al.
Clin Cancer Res
. 2024 Oct;
30(20):4801.
PMID: 39402969
No abstract available.
8.
Erlandson K, Geng L, Selvaggi C, Thaweethai T, Chen P, Erdmann N, et al.
Ann Intern Med
. 2024 Aug;
177(9):1209-1221.
PMID: 39133923
Background: There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC). Objective: To investigate clinical laboratory markers of SARS-CoV-2 and PASC. Design: Propensity score-weighted linear regression...
9.
Rashid M, Rashid R, Saroya S, Deverapalli M, Brim H, Ashktorab H
Nutrients
. 2024 Jul;
16(14).
PMID: 39064796
Inflammatory bowel disease (IBD) is a chronic inflammatory illness of the gastrointestinal tract (GI), characterized by recurrent episodes of inflammation and tissue destruction. It affects an increasing number of individuals...
10.
Ishikawa A, Fukui T, Kido A, Katsuya N, Kuraoka K, Uraoka N, et al.
Cancer Sci
. 2024 Jul;
115(9):3180-3193.
PMID: 39021298
Gastric cancer (GC) is characterized by significant intratumoral heterogeneity, and stem cells are promising therapeutic targets. Despite advancements in spatial transcriptome analyses, unexplored targets for addressing cancer stemness remain unknown....